Cargando…
Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial
BACKGROUND Inflammatory bowel diseases are managed by different methods, which may not be well tolerated because of their side effects. Recently, pro-prebiotics are considered as a supplementary treatment in gastrointestinal diseases. In this study, the effect of Lactocare® (ZistTakhmir Company) was...
Autores principales: | Amiriani, Taghi, Rajabli, Niloofar, Faghani, Maryam, Besharat, Sima, Roshandel, Gholamreza, Akhavan Tabib, Atefeh, Joshaghani, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023645/ https://www.ncbi.nlm.nih.gov/pubmed/32082518 http://dx.doi.org/10.15171/mejdd.2020.160 |
Ejemplares similares
-
Correlation Between Low Bone Density and Disease Activity in Patients with Ulcerative Colitis
por: Amiriani, Taghi, et al.
Publicado: (2015) -
The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Akbarzadeh, Ali, et al.
Publicado: (2022) -
comparison of the Serum Levels of Trace Elements in Areas with High or Low Rate of Esophageal Cancer
por: Joshaghani, Hamidreza, et al.
Publicado: (2017) -
Evaluation of Lactocare® Synbiotic Administration on the Serum Electrolytes and Trace Elements Levels in Psoriasis Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Study
por: Akbarzadeh, Ali, et al.
Publicado: (2021) -
Heartburn in Staff of Golestan Medical University, Northeast of Iran
por: Besharat, Sima, et al.
Publicado: (2009)